Numerai GP LLC trimmed its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 34.2% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,739 shares of the company's stock after selling 9,759 shares during the period. Numerai GP LLC's holdings in Ryan Specialty were worth $1,202,000 at the end of the most recent reporting period.
Other hedge funds have also bought and sold shares of the company. Rakuten Securities Inc. acquired a new position in Ryan Specialty in the fourth quarter worth about $27,000. Kapitalo Investimentos Ltda bought a new position in Ryan Specialty in the fourth quarter worth about $36,000. Principal Securities Inc. lifted its holdings in Ryan Specialty by 164.7% in the fourth quarter. Principal Securities Inc. now owns 667 shares of the company's stock worth $43,000 after acquiring an additional 415 shares during the last quarter. Mizuho Bank Ltd. bought a new position in Ryan Specialty in the fourth quarter worth about $49,000. Finally, Headlands Technologies LLC lifted its holdings in Ryan Specialty by 2,644.8% in the fourth quarter. Headlands Technologies LLC now owns 796 shares of the company's stock worth $51,000 after acquiring an additional 767 shares during the last quarter. 84.82% of the stock is currently owned by institutional investors and hedge funds.
Ryan Specialty Price Performance
NYSE:RYAN traded up $0.80 during midday trading on Friday, hitting $70.67. 672,673 shares of the stock were exchanged, compared to its average volume of 979,617. Ryan Specialty Holdings, Inc. has a one year low of $52.34 and a one year high of $77.16. The company has a market capitalization of $18.55 billion, a price-to-earnings ratio of 102.42, a P/E/G ratio of 1.19 and a beta of 0.68. The business has a 50-day moving average price of $70.16 and a two-hundred day moving average price of $68.73. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40.
Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.39. The firm had revenue of $690.17 million for the quarter, compared to analyst estimates of $680.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The firm's quarterly revenue was up 25.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.35 earnings per share. Sell-side analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.
Ryan Specialty Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th will be given a $0.12 dividend. The ex-dividend date is Tuesday, May 13th. This represents a $0.48 annualized dividend and a yield of 0.68%. Ryan Specialty's dividend payout ratio (DPR) is 141.18%.
Insiders Place Their Bets
In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 11.10% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
A number of equities analysts have issued reports on the stock. Barclays cut their target price on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a report on Friday, April 11th. Royal Bank of Canada cut their target price on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a report on Friday, February 21st. Keefe, Bruyette & Woods cut their target price on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. The Goldman Sachs Group raised shares of Ryan Specialty from a "neutral" rating to a "buy" rating and raised their target price for the stock from $74.00 to $81.00 in a report on Tuesday. Finally, TD Cowen initiated coverage on Ryan Specialty in a report on Thursday, April 10th. They set a "buy" rating and a $89.00 price target on the stock. One analyst has rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, Ryan Specialty has a consensus rating of "Moderate Buy" and an average target price of $76.42.
View Our Latest Research Report on Ryan Specialty
About Ryan Specialty
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
See Also
Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
